BHC:CC News and Press, Bausch Health Companies Inc. From 07/29/25

2025-07-29 08:35:55 ET More on Bausch Health Companies, DURECT Bausch Health: Repricing Potential Driven By Deleveraging Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation ...

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease PR Newswire DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation ...

2025-07-28 09:49:23 ET More on Bausch Health Companies Bausch Health: Repricing Potential Driven By Deleveraging Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation Ba...

LAVAL, QC / ACCESS Newswire / July 28, 2025 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company") today announced that its subsidiary, Bausch Health Americas, Inc., has issued an irrevocable notice of redemption pursuant to which it will redeem approximately $...

LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective July 22, 2025. The appointments increase the s...

2025-07-17 21:30:00 ET The Canadian healthcare space is a good, defensive place to turn in times of economic uncertainty. These days, tariffs, inflation, and general economic worries are leading many investors to look for healthcare stocks for shelter. While there aren’t many cho...

This press release updates the headline of the previously posted release LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and benzoyl p...

LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Steven Lee as Senior Vice President, Controller and Chief Accounting Officer, effective Monday, July 14. Steven brin...

2025-07-10 16:00:00 ET There are a myriad of incredible stocks to choose from in the market (and potentially as many traps to be avoided) for the average investor. Indeed, doing one’s homework on which stocks are worthy of an investment today can save a given investor a heck of a lot...

LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgar...